2Points to consider on plasmid DNA vaccines for preventive infectious disease indications.Food and Drug Administration Center for Biologics Evaluation and Research office of Vaccine Research and Review.1996,Docket No.96-N-0400.
3WHO.Tech Rep Ser.1998,No.878.
4Temin HM.Overview of biological effects of addition of DNA moleculars to cells.J Med Virol,1990,31(1):13-17.
5Robertson JS.Safety considerations for nucleic acid vaccines.Vaccine,1994,12(16):1526-1528.
6Bushman F,Landou NR,Emini EA.New developments in the biology and treatment of HIV.PNAS,1998,95(19):11041-11042.
7Schroder AR,Shinn P,Chen H,et al.HIV-1 integration in the human genome favors active genes and local hotspot.Cell,2002,110(4):521-529.
8Polling AM,Harman RM,Jones SA,et al.The assessment of local tolerance,acute toxicity,and DNA biodistribution following particle-mediated delivery of a DNA vaccine to minipigs.Toxicol Pathol,2002,30(3):298-305.
9Wolff JA,Ludtke JJ,Ascadi G,et al.Long-term persistence of plasmid DNA and foreign gene expression in muscle.Hum Mol Genet,1992,1(6):363-369.
1Roy MJ,Wu MS,Barr LJ,et al.Induction of antigen-specific CD8 +T cells,T helper cells,and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine[J].Vaccine,2000,19(7-8):764-778.
2Watabe S,Xin KQ,Ihata A,et al.Protection against influenza virus challenge by topical application of influenza DNA vaccine[J].Vaccine,2001,19(31):4434-4444.
3Tadokoro K,Koizumi Y,Miyagi Y,et al.Rapid and wide-reaching delivery of HIV-1 env DNA vaccine by intranasal administration[J].Viral Immunol,2001,14(2):159-167.
4Scheerlinck JY.Genetic adjuvants for DNA vaccines [ J ].Vaccine,2001,19(17-19):2647-2656.
5Krishnan BR.Current status of DNA vaccines in veterinary medicine[J].Advanced drug delivery reviews,2000,43( 1 ):3-11.
6Davis HL,McCluskie MJ,Gerin JL,et al.DNA vaccine for hepatitis B:evidence for immunogenicity in chimpanzees and comparison with other vaccines[J].Proc Ncad Sci USA,1996,93(14):7213-7218.
7Akbari O,Panjwani N,Garcia S.DNA vaccination:transfection and activation of dendritic cells as key events for immunity [ J ].J Exp Med,1999,189(1):169-178.
8Stratford R,Douce G,Zhang BL,et al.Influence of codon usage on the immunogenicity of a DNA vaccine against tetanus[J].Vaccine,2000,19(7-8):810-815.
9Liu LJ,Watabe S,Yang J,et al.Topical application of HIV DNA vaccine with cytokine-expression plasmids induces strong antigenspecific immune responses [ J ].Vaccine,2001 ,20 ( 1-2):42-48.
